Senators Question HHS’ Innovation Initiatives

During a U.S. Senate Finance Committee hearing on Wednesday, lawmakers questioned the efficacy of cost control initiatives managed by HHS' Center for Medicare and Medicaid Innovations. The Affordable Care Act provided CMMI with $10 billion to develop and test care delivery models that aim to boost quality and lower costs. CMMI Director Richard Gilfillan defended the initiatives, saying that that it "will take time to see the improvements we are after."

• "Orrin Hatch Warns on Medicare Payment Experiments Under ACA" (Winfield Cunningham, Politico, 3/21).
• "U.S. Health Innovations Need Time To Show Cost Results: Official" (Morgan, Reuters, 3/20).